The contribution of porins to enterobacterial drug resistance

J Antimicrob Chemother. 2024 Oct 1;79(10):2460-2470. doi: 10.1093/jac/dkae265.

Abstract

In Enterobacteriaceae, susceptibility to cephalosporins and carbapenems is often associated with membrane and enzymatic barrier resistance. For about 20 years, a large number of Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae presenting ß-lactam resistance have been isolated from medical clinics. In addition, some of the resistant isolates exhibited alterations in the outer membrane porin OmpC-OmpF orthologues, resulting in the complete absence of gene expression, replacement by another porin or mutations affecting channel properties. Interestingly, for mutations reported in OmpC-OmpF orthologues, major changes in pore function were found to be present in the gene encoding for OmpC. The alterations were located in the constriction region of the porin and the resulting amino acid substitutions were found to induce severe restriction of the lumen diameter and/or alteration of the electrostatic field that governs the diffusion of charged molecules. This functional adaptation through porins maintains the entry of solutes necessary for bacterial growth but critically controls the influx of harmful molecules such as β-lactams at a reduced cost. The data recently published show the importance of understanding the underlying parameters affecting the uptake of antibiotics by infectious bacteria. Furthermore, the development of reliable methods to measure the concentration of antibiotics within bacterial cells is key to combat impermeability-resistance mechanisms.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Enterobacteriaceae Infections* / microbiology
  • Enterobacteriaceae* / drug effects
  • Enterobacteriaceae* / genetics
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Escherichia coli Proteins* / genetics
  • Escherichia coli Proteins* / metabolism
  • Humans
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / genetics
  • Microbial Sensitivity Tests
  • Mutation
  • Porins* / genetics
  • Porins* / metabolism
  • beta-Lactam Resistance* / genetics

Substances

  • Anti-Bacterial Agents
  • OmpC protein
  • Porins
  • Escherichia coli Proteins